The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The implantable pulse generator market size has experienced significant growth in recent years, projected to rise from $99.52 billion in 2023 to $107.09 billion in 2024, at a compound annual growth rate (CAGR) of 7.6%. This historic growth can be attributed to the increasing number of home healthcare facilities, a higher adoption of neuromodulation in disease management, improved patient diagnosis rates, a rise in the usage of medical devices, and greater patient awareness. Looking ahead, the market size is anticipated to reach $144.31 billion in 2028, growing at a CAGR of 7.7%. This forecasted growth is driven by increasing healthcare expenditure, patient preferences for less invasive treatments, favorable reimbursement policies, expanded application areas, and the growing use of implants in various therapies. Major trends shaping the forecast period include miniaturization of devices, enhanced battery life, development of wireless connectivity, smart implantable devices, and the integration of artificial intelligence and machine learning.

A rise in the incidence of neurological disorders is projected to boost the growth of the implantable pulse generator market in the coming years. Neurological disorders encompass conditions that impact the brain, spinal cord, and nervous system, affecting various functions such as movement, sensation, and cognition. The increase in neurological disorder cases can often be attributed to aging populations, lifestyle changes, environmental factors, and advancements in diagnostic techniques. Implantable pulse generators address these disorders by delivering targeted electrical impulses that modulate abnormal neural activity, alleviating symptoms. For instance, the Parkinson Foundation noted in December 2022 that the number of individuals with Parkinson’s disease (PD) in the U.S. was 930,000 by 2020, with projections indicating this figure could rise to 1.2 million by 2030. Consequently, the escalating incidence of neurological disorders is driving the growth of the implantable pulse generator market through 2023, into 2024, and is expected to continue expanding by 2028.

Get A Free Sample On The Implantable Pulse Generator Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp

What Are The Key Trends That Influence Implantable Pulse Generator Market Share Analysis?

Major companies in the implantable pulse generator market are increasingly focusing on the development of advanced neuromodulation devices to enhance treatment efficacy, improve patient outcomes, and broaden the applicability of these devices to a wider range of neurological conditions. A neuromodulation device is designed to alter nerve activity by delivering electrical signals or pharmaceutical agents directly to specific areas of the nervous system. For example, in November 2022, CVRx Inc., a US-based medical device company, launched the Barostim NEO2 IPG, an implantable pulse generator for patients receiving therapy. The Barostim system utilizes neuromodulation to alleviate heart failure symptoms by delivering electrical pulses to the baroreceptors located in the carotid artery wall. This stimulation activates the body’s baroreflex, which triggers an autonomic response in the heart, aiming to restore balance to the autonomic nervous system and relieve heart failure symptoms.

Which Market Players Are Driving Growth In The Implantable Pulse Generator Market?

Major companies operating in the implantable pulse generator market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Integer Holdings Corporation, Livanova plc, Inspire Medical Systems Inc., Nevro Corp, Impulse Dynamics Ltd., Valtronic Inc., NeuroPace Inc., SPR Therapeutics Inc., Stimwave LLC, SetPoint Medical, ReShape Lifesciences Inc., Synapse Biomedical Inc., Nuvectra Medical Inc., NeuroSigma Inc., Nalu Medical Inc., MainStay Medical International PLC, Dextronix Inc., BioControl Medical Inc.

How Is The Global Implantable Pulse Generator Market Segmented?

The implantable pulse generator market covered in this report is segmented –

1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices
2) By Charging Type: Rechargeable, Non Rechargeable
3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics

Read The Full Implantable Pulse Generator Market Report Here

https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report

The Implantable Pulse Generator Global Market Report 2024 provides an overview of the implantable pulse generatormarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The implantable pulse generator market forecast analyzes implantable pulse generator market size, implantable pulse generator market share, leading competitor and their market positions.

The Table Of Content For The Implantable Pulse Generator Market Include

1. Implantable Pulse Generator Market Executive Summary
2. Implantable Pulse Generator Market Segments
3. Implantable Pulse Generator Market Size And Template Market Growth Rate
4.  Key Implantable Pulse Generator Market Trends
5. Major Implantable Pulse Generator Market Drivers
……
25. Key Mergers And Acquisitions In The Implantable Pulse Generator Market
26. Top Implantable Pulse Generator Companies
27. Implantable Pulse Generator Market Opportunities And Strategies
28. Implantable Pulse Generator Market, Conclusions And Recommendations
29. Appendix

Explore Similar Reports From The Business Research Company:

Implantable Biomaterials Market 2024

https://www.thebusinessresearchcompany.com/report/implantable-biomaterials-global-market-report

Implantable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Implantable Infusion Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model